This hypothesis was strengthened recently when a meta-analysis of over 1000 patients identified amplification of CCND1 (encoding Cyclin D1) as one of the strongest tumor-intrinsic predictors of resistance to ICI30. This evidence concerns the gene CCND1 and neoplasm.